Search research articles
Contact Us
Filters
Showing results (31-40 of 69) with videos related to
Page
of 7
Sort By:
Paediatric Drugs
|
June 13, 2013
Combination pharmacotherapy for psychiatric disorders in children and adolescents: prevalence, efficacy, risks and research needs
Jon Jureidini, Anne Tonkin, Elsa Jureidini
Communication & Medicine
|
June 30, 2018
How language shapes psychiatric case formulation
John Walsh, Nayia Cominos, Jon Jureidini
Lancet (London, England)
|
December 5, 2003
The stain wars
Jon Jureidini, Peter Mansfield, David Menkes
Frontiers in Psychiatry
|
June 27, 2020
Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends
Martin Whitely, Melissa Raven, Jon Jureidini
Pharmacoeconomics
|
June 20, 2008
Does direct-to-consumer advertising of antidepressants lead to a net social benefit?
Jon Jureidini, Barbara Mintzes, Melissa Raven
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|
March 22, 2005
Partnerships between academic psychiatry and the pharmaceutical industry
Melissa Raven, Wendy Rogers, Jon Jureidini
BMJ (Clinical Research Ed.)
|
October 30, 2008
NICE guidance on ADHD. NICE recommendations are not evidence based and could expose many to unnecessary harm
Sami Timimi, Jon Jureidini, Jonathan Leo
The International Journal of Risk & Safety in Medicine
|
June 6, 2018
Paediatric antidepressants: Benefits and risks
David Healy, Joanna Le Noury, Jon Jureidini
The Australian and New Zealand Journal of Psychiatry
|
January 17, 2012
'Prodromal' diagnosis of psychosis: Ethical problems in research and clinical practice
Melissa Raven, Geoffrey W Stuart, Jon Jureidini
The Australian and New Zealand Journal of Psychiatry
|
July 2, 2013
Transparency and accountability in early psychosis intervention research
Melissa Raven, Jon Jureidini, Geoffrey W Stuart
Page
of 7
Search research articles
Search
Showing results (31-40 of 69) with videos related to
Sort By:
Page
of 7
Paediatric Drugs
|
June 13, 2013
Combination pharmacotherapy for psychiatric disorders in children and adolescents: prevalence, efficacy, risks and research needs
Jon Jureidini, Anne Tonkin, Elsa Jureidini
Communication & Medicine
|
June 30, 2018
How language shapes psychiatric case formulation
John Walsh, Nayia Cominos, Jon Jureidini
Lancet (London, England)
|
December 5, 2003
The stain wars
Jon Jureidini, Peter Mansfield, David Menkes
Frontiers in Psychiatry
|
June 27, 2020
Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends
Martin Whitely, Melissa Raven, Jon Jureidini
Pharmacoeconomics
|
June 20, 2008
Does direct-to-consumer advertising of antidepressants lead to a net social benefit?
Jon Jureidini, Barbara Mintzes, Melissa Raven
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|
March 22, 2005
Partnerships between academic psychiatry and the pharmaceutical industry
Melissa Raven, Wendy Rogers, Jon Jureidini
BMJ (Clinical Research Ed.)
|
October 30, 2008
NICE guidance on ADHD. NICE recommendations are not evidence based and could expose many to unnecessary harm
Sami Timimi, Jon Jureidini, Jonathan Leo
The International Journal of Risk & Safety in Medicine
|
June 6, 2018
Paediatric antidepressants: Benefits and risks
David Healy, Joanna Le Noury, Jon Jureidini
The Australian and New Zealand Journal of Psychiatry
|
January 17, 2012
'Prodromal' diagnosis of psychosis: Ethical problems in research and clinical practice
Melissa Raven, Geoffrey W Stuart, Jon Jureidini
The Australian and New Zealand Journal of Psychiatry
|
July 2, 2013
Transparency and accountability in early psychosis intervention research
Melissa Raven, Jon Jureidini, Geoffrey W Stuart
Page
of 7